Outcomes of a co-located approach for metabolic health care for people with schizophrenia

Australas Psychiatry. 2022 Aug;30(4):518-522. doi: 10.1177/10398562221080742. Epub 2022 Mar 24.

Abstract

Objective: Metabolic syndrome is highly prevalent among people with schizophrenia. This study aims to assess the impact on metabolic and attendance outcomes of a co-located, dedicated, endocrinologist-led metabolic clinic in a stand-alone public community mental health service.

Methods: Demographic and metabolic data on the first 48 consecutive referrals over a 12-month period were retrospectively collected and analysed. Attendance rates at the co-located clinic were compared to the general hospital obesity and diabetes clinics.

Results: Clinic attendees had significant reductions in triglycerides and total cholesterol, but not mean weight, BMI, waist circumference, blood pressure or HbA1c. Attendance rates were significantly higher in the co-located clinic compared to the general hospital obesity and diabetes clinics for both initial consult (80.0% vs 51.2%, p < 0.001) and review appointment (64.3% vs 47.6%, p < 0.001).

Conclusion: The co-location of a specialist metabolic clinic within a mental health service resulted in enhanced engagement and improvement of metabolic health in people with schizophrenia.

Keywords: co-location; dyslipidaemia; mental health; metabolic syndrome; schizophrenia.

MeSH terms

  • Delivery of Health Care
  • Diabetes Mellitus*
  • Humans
  • Metabolic Syndrome* / therapy
  • Obesity
  • Retrospective Studies
  • Schizophrenia* / therapy